Illumina

YTD

ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R.

CEO

Jacob Thaysen

CEOJacob Thaysen

Employees

8,600

Employees8,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

8,600

Employees8,600

ILMN Key Statistics

Market cap

33.24B

Market cap33.24B

Price-Earnings ratio

39.74

Price-Earnings ratio39.74

Dividend yield

—

Dividend yield—

Average volume

2.01M

Average volume2.01M

High today

$220.23

High today$220.23

Low today

$210.94

Low today$210.94

Open price

$214.40

Open price$214.40

Volume

1.10M

Volume1.10M

52 Week high

$231.81

52 Week high$231.81

52 Week low

$88.00

52 Week low$88.00

Stock Snapshot

With a market cap of 33.24B, Illumina(ILMN) trades at $220.15. The stock has a price-to-earnings ratio of 39.74.

As of 2026-09-03, Illumina(ILMN) stock has fluctuated between $210.94 and $220.23. The current price stands at $220.15, placing the stock +4.4% above today's low and -0.0% off the high.

Illumina(ILMN) shares are trading with a volume of 1.1M, against a daily average of 2.01M.

During the past year, Illumina(ILMN) stock moved between $88.00 at its lowest and $231.81 at its peak.

ILMN News

TipRanks 8h

Illumina price target raised to $235 from $180 at Argus

Argus raised the firm’s price target on Illumina (ILMN) to $235 from $180 and keeps a Buy rating on the shares. Illumina is currently working on several new pro...

Simply Wall St 1d

Illumina Stock Looks Cheap On Cash Flow Yet Pricey On Earnings - simplywall.st

...

TipRanks 3d

Novacyt strikes five-year collaboration framework with Illumina

Novacyt ( (FR:ALNOV) ) just unveiled an update. Novacyt has signed a five-year Master Collaboration Agreement with Illumina, the DNA sequencing specialist, cre...

Analyst ratings

48%

of 23 ratings

Buy

47.8%

Hold

34.8%

Sell

17.4%

More ILMN News

TipRanks 5d

Charles Schwab, Tonix, Boston Scientific, Alcoa, Illumina

Insiders have been trading these 5 stocks: ((SCHW)), ((TNXP)), ((BSX)), ((AA)) and ((ILMN)). Here is a breakdown of their recent trades and their value. Co-Cha...

Nasdaq 6d

Should You Add Illumina Stock to Your Portfolio Now?

Illumina Inc. ILMN is well positioned for growth in the coming quarters, driven by strategic execution focused on growing its core sequencing business, expandin...

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.